658
Views
27
CrossRef citations to date
0
Altmetric
Review

Ebola virus vaccines – reality or fiction?

, , &
Pages 1421-1430 | Received 23 Feb 2016, Accepted 11 Apr 2016, Published online: 09 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Igor Morozov, Thomas P. Monath, David A. Meekins, Jessie D. Trujillo, Sun-Young Sunwoo, Kinga Urbaniak, In Joong Kim, Sanjeev K. Narayanan, Sabarish V. Indran, Wenjun Ma, William C. Wilson, Cassandra O'Connor, Sheri Dubey, Sean P. Troth, Beth-Ann Coller, Richard Nichols, Brian K. Martin, Heinz Feldmann & Juergen A. Richt. (2021) High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission. Emerging Microbes & Infections 10:1, pages 651-663.
Read now
Ellen Suder, Wakako Furuyama, Heinz Feldmann, Andrea Marzi & Emmie de Wit. (2018) The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials. Human Vaccines & Immunotherapeutics 14:9, pages 2107-2113.
Read now
Harriet L. Robinson & Andrea Marzi. (2018) Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine. Expert Review of Vaccines 17:9, pages 769-771.
Read now
Katie Ewer, Sarah Sebastian, Alexandra J. Spencer, Sarah Gilbert, Adrian V. S. Hill & Teresa Lambe. (2017) Chimpanzee adenoviral vectors as vaccines for outbreak pathogens. Human Vaccines & Immunotherapeutics 13:12, pages 3020-3032.
Read now

Articles from other publishers (23)

Alexandra Kupke, Asisa Volz, Erik Dietzel, Astrid Freudenstein, Jörg Schmidt, Hosam Shams-Eldin, Sylvia Jany, Lucie Sauerhering, Verena Krähling, Michelle Gellhorn Serra, Christiane Herden, Markus Eickmann, Stephan Becker & Gerd Sutter. (2022) Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines 10:4, pages 533.
Crossref
Mohammad Behdad Jamshidi, Jakub Talla, Ali Lalbakhsh, Maryam S. Sharifi-Atashgah, Asal Sabet & Zdenek Peroutka. (2021) A Conceptual Deep Learning Framework for COVID-19 Drug Discovery. A Conceptual Deep Learning Framework for COVID-19 Drug Discovery.
Aqsa Farman, Syed Lal Badshah, Khalid Khan, Nasir Ahmad & Abdul Naeem. 2021. Some RNA Viruses. Some RNA Viruses.
Ravi Potluri, Amit Kumar, Vikalp Maheshwari, Charlie Smith, Valerie Oriol Mathieu, Kerstin Luhn, Benoit Callendret & Hitesh Bhandari. (2020) Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis. PLOS ONE 15:4, pages e0230406.
Crossref
Jenny A. Walldorf, Emily A. Cloessner, Terri B. Hyde, Adam MacNeil, Sarah D. Bennett, Rosalind J. Carter, John T. Redd & Barbara J. Marston. (2019) Considerations for use of Ebola vaccine during an emergency response. Vaccine 37:48, pages 7190-7200.
Crossref
Andrea Marzi, Pierce Reynolds, Reinaldo Mercado-Hernandez, Julie Callison, Friederike Feldmann, Rebecca Rosenke, Tina Thomas, Dana P. Scott, Patrick W. Hanley, Elaine Haddock & Heinz Feldmann. (2019) Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge. eBioMedicine 49, pages 223-231.
Crossref
Andrea Marzi & Chad E. Mire. (2019) Current Ebola Virus Vaccine Progress. BioDrugs 33:1, pages 9-14.
Crossref
Aleksandra Drelich, Barbara Judy, Xi He, Qing Chang, Shangyi Yu, Xiang Li, Fanglin Lu, Maki Wakamiya, Vsevolod Popov, Jia Zhou, Thomas Ksiazek & Bin Gong. (2018) Exchange Protein Directly Activated by cAMP Modulates Ebola Virus Uptake into Vascular Endothelial Cells. Viruses 10:10, pages 563.
Crossref
Heinz Feldmann, Friederike Feldmann & Andrea Marzi. (2018) Ebola: Lessons on Vaccine Development. Annual Review of Microbiology 72:1, pages 423-446.
Crossref
Samira Locher, Marc Schweneker, Jürgen Hausmann & Gert Zimmer. (2018) Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs. Journal of General Virology 99:7, pages 866-879.
Crossref
Mariano Sanchez-Lockhart, Daniel S. Reyes, Jeanette C. Gonzalez, Karla Y. Garcia, Erika C. Villa, Bradley P. Pfeffer, John C. Trefry, Jeffrey R. Kugelman, Margaret L. Pitt & Gustavo F. Palacios. (2018) Qualitative Profiling of the Humoral Immune Response Elicited by rVSV-ΔG-EBOV-GP Using a Systems Serology Assay, Domain Programmable Arrays. Cell Reports 24:4, pages 1050-1059.e5.
Crossref
Angela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, José F Fernandes, Emmanuel Bache Bache, Lumeka Kabwende, Francis Maina Ndungu, Jessica Brosnahan, Thomas P Monath, Barbara Lemaître, Stéphane Grillet, Miriam Botto, Olivier Engler, Jasmine Portmann, Denise Siegrist, Philip Bejon, Peter Silvera, Peter Kremsner, Claire-Anne Siegrist, Sanjeev KRISHNA, Marylyn M. ADDO, Stephan BECKER, Verena KRÄHLING, Patricia NJUGUNA, Marie-Paule KIENY, Rafi AHMED, Jenna ANDERSON, Floriane AUDERSET, Luisa BORGIANNI, Annalisa CIABATTINI, Marielle C. HAKS, Ali HARANDI, Donald Gray HEPPNER, Alice GERLINI, Donata MEDAGLINI, Tom H.M. OTTENHOFF, David PEJOSKI, Mark PAGE, Gianni POZZI, Francesco SANTORO, Sheri DUBEY, José F. FERNANDES, Helder NAKAYA, Fiona OROURKE, Gianni POZZI & Sylvia ROTHENBERGER. (2018) Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study. The Lancet Infectious Diseases 18:7, pages 738-748.
Crossref
. (2018) Filovirus – Auslöser von hämorrhagischem Fieber. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 61:7, pages 894-907.
Crossref
Michael K. Lo, Paul C. Jordan, Sarah Stevens, Yuen Tam, Jerome Deval, Stuart T. Nichol & Christina F. Spiropoulou. (2018) Susceptibility of paramyxoviruses and filoviruses to inhibition by 2′-monofluoro- and 2′-difluoro-4′-azidocytidine analogs. Antiviral Research 153, pages 101-113.
Crossref
Arban Domi, Friederike Feldmann, Rahul Basu, Nathanael McCurley, Kyle Shifflett, Jackson Emanuel, Michael S. Hellerstein, Farshad Guirakhoo, Chiara Orlandi, Robin Flinko, George K. Lewis, Patrick W. Hanley, Heinz Feldmann, Harriet L. Robinson & Andrea Marzi. (2018) A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge. Scientific Reports 8:1.
Crossref
Ian R. Humphreys & Sarah Sebastian. (2018) Novel viral vectors in infectious diseases. Immunology 153:1, pages 1-9.
Crossref
Jenny A. Walldorf, Kashmira A. Date, Nandini Sreenivasan, Jennifer B. Harris & Terri B. Hyde. (2017) Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola. Emerging Infectious Diseases 23:13.
Crossref
Marie Luisa Schmidt & Thomas Hoenen. (2017) Characterization of the catalytic center of the Ebola virus L polymerase. PLOS Neglected Tropical Diseases 11:10, pages e0005996.
Crossref
Nicholas J. Lennemann, Andrew S. Herbert, Rachel Brouillette, Bethany Rhein, Russell A. Bakken, Katherine J. Perschbacher, Ashley L. Cooney, Catherine L. Miller-Hunt, Patrick Ten Eyck, Julia Biggins, Gene Olinger, John M. Dye & Wendy Maury. (2017) Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice. Journal of Virology 91:17.
Crossref
Tan Chen, Dapeng Li, Yufeng Song, Xi Yang, Qingwei Liu, Xia Jin, Dongming Zhou & Zhong Huang. (2017) A heterologous prime-boost Ebola virus vaccine regimen induces durable neutralizing antibody response and prevents Ebola virus-like particle entry in mice. Antiviral Research 145, pages 54-59.
Crossref
Mary K. Yates, Mithun R. Raje, Payel Chatterjee, Christina F. Spiropoulou, Sina Bavari, Mike Flint, Veronica Soloveva & Katherine L. Seley-Radtke. (2017) Flex-nucleoside analogues – Novel therapeutics against filoviruses. Bioorganic & Medicinal Chemistry Letters 27:12, pages 2800-2802.
Crossref
Sergio Rosales-Mendoza, Ricardo Nieto-Gómez & Carlos Angulo. (2017) A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus. Frontiers in Immunology 8.
Crossref
Joseph B. Prescott, Andrea Marzi, David Safronetz, Shelly J. Robertson, Heinz Feldmann & Sonja M. Best. (2017) Immunobiology of Ebola and Lassa virus infections. Nature Reviews Immunology 17:3, pages 195-207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.